RecruitingNCT02803242

COPD Patient-Powered Research Network


Sponsor

COPD Foundation

Enrollment

75,000 participants

Start Date

Aug 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they qualify for and become connected to COPD resources. The goal of the registry is to speed research to find better treatments for COPD and ultimately a cure.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a research network of patients with COPD (a serious lung disease) or other lung problems, so that people with breathing conditions can help drive and shape future research. **You may be eligible if...** - You are 18 years or older AND at least one of the following applies to you: - You have been diagnosed with COPD (chronic obstructive pulmonary disease) - You are a current or former smoker - A close family member has had a respiratory (breathing) disease - You have symptoms of a respiratory disease such as shortness of breath, chronic cough, or wheezing **You may NOT be eligible if...** - You do not speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient Reported Outcomes

Locations(1)

COPD Foundation

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02803242


Related Trials